{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:34:40Z","timestamp":1777660480422,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HAB"],"published-print":{"date-parts":[[2022,2,18]]},"abstract":"<jats:p>BACKGROUND: Interleukin (IL)-17 plays a central role in orchestrating the cytokine cascade and accelerates atherosclerosis and plaque vulnerability in animal models. However, epidemiological data evaluating the role of IL-17 levels in unstable angina are lacking. The aim of our study is to evaluate and compare the IL-17 levels in unstable angina (UA) cases before and after treatment. METHODS: This cross-sectional study was performed from July to October 2018 in Ali Iben-abitaleb heart center, Zahedan, Iran. 48 patients with UA in the age range of below 50 years entered the study. All demographic, past medical history, physical examination, electrocardiogram (EKG or ECG), and transthoracic echocardiogram (TTE) data were collected. Serum level of IL-17 was measured using enzyme-linked immunosorbent assay (ELISA) method. In all the tests, P&lt; 0.05 was considered as statistically significant. All data analyses were performed using the SPSS 13.0 software (SPSS Inc., Chicago, Illinois, USA). RESULTS: In this study, 48 UA patients, including 34 women and 16 men with a mean age of 56.60 years were included in the study. The mean serum level of interleukin 17 after treatment (65.13 \u00b1 53.29\u00a0pg\/dl) was significantly lower than Its level before treatment (94.89 \u00b1 51.25\u00a0pg\/dL) (P&lt; 0\/05). CONCLUSION: Our findings point towards a role of inflammation in the form of increased activity of IL-17 in UA patients and thus suggest that IL-17-driven inflammation may play a role in the promotion of clinical instability in patients with coronary artery disease.<\/jats:p>","DOI":"10.3233\/hab-210446","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T12:43:53Z","timestamp":1622810633000},"page":"25-29","source":"Crossref","is-referenced-by-count":3,"title":["The comparison of IL-17 levels in patients with unstable angina before and after medical\u00a0treatment"],"prefix":"10.1177","volume":"30","author":[{"given":"Ahmad","family":"Boluri","sequence":"first","affiliation":[{"name":"Cardiology, Zahedan University of Medical Sciences, Zahedan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosseinali","family":"Khazaei","sequence":"additional","affiliation":[{"name":"Medical Immunology and Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narjes","family":"Sargolzaei","sequence":"additional","affiliation":[{"name":"Community Medicine and Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanie Olfat","family":"Miri","sequence":"additional","affiliation":[{"name":"Zahedan University of Medical Sciences, Zahedan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Khazaei","sequence":"additional","affiliation":[{"name":"Zahedan University of Medical Sciences, Zahedan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/HAB-210446_ref1","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1515\/CCLM.2004.232","article-title":"Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes","volume":"42","author":"Brueckmann","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.3233\/HAB-210446_ref2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpes virus Saimiri encodes a new cytokine, IL-7 which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"},{"key":"10.3233\/HAB-210446_ref3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.3233\/HAB-210446_ref4","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.3233\/HAB-210446_ref5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1523-1747.2000.00041.x","article-title":"IL17 is produced by both Th1 and Th2 Lymphocytes and modulates Interferon-g and IL4 induced activation of keratinocytes","volume":"115","author":"Albanesi","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"Suppl","key":"10.3233\/HAB-210446_ref6","first-page":"S272","article-title":"Analysis of IL-17 and other cytokines and surface markers of RA inflammatory T cell clones","volume":"40","author":"Aarvak","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.3233\/HAB-210446_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: Prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.3233\/HAB-210446_ref8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"10.3233\/HAB-210446_ref9","doi-asserted-by":"crossref","first-page":"G1035","DOI":"10.1152\/ajpgi.00494.2001","article-title":"IL-17 stimulates inflammatory responses via NF-kB and MAP kinase pathways in human colonic myofibroblasts","volume":"282","author":"Hata","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.3233\/HAB-210446_ref10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cytogfr.2003.10.003","article-title":"Inducible nitric oxide synthase activation by interleukin-17","volume":"15","author":"Miljkovic","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.3233\/HAB-210446_ref11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.3233\/HAB-210446_ref12","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","article-title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism","volume":"164","author":"Ziolkowska","year":"2000","journal-title":"J Immunol"},{"key":"10.3233\/HAB-210446_ref13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.3233\/HAB-210446_ref14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","article-title":"Interleukin-17 and interferon-g synergize in the enhancement of proinflammatory cytokine production by human keratinocytes","volume":"111","author":"Teunissen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.3233\/HAB-210446_ref15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4049\/jimmunol.162.1.577","article-title":"Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors","volume":"162","author":"Antonysamy","year":"1999","journal-title":"J Immunol"},{"key":"10.3233\/HAB-210446_ref16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/path.1117","article-title":"Evidence for early involvement of interleukin 17 in human and experimental renal allograft rejection","volume":"197","author":"Loong","year":"2002","journal-title":"J Pathol"},{"key":"10.3233\/HAB-210446_ref17","doi-asserted-by":"crossref","first-page":"B28","DOI":"10.1016\/0002-9149(91)90382-U","article-title":"Coronary thrombosis: Pathogenesis and clinical manifestations","volume":"68","author":"Falk","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.3233\/HAB-210446_ref18","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"key":"10.3233\/HAB-210446_ref19","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.CIR.94.8.2013","article-title":"Stability and instability: Two faces of coronary atherosclerosis; Paul Dudley White Lecture 1995","volume":"94","author":"Davies","year":"1996","journal-title":"Circulation"},{"key":"10.3233\/HAB-210446_ref20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes; Implications for plaque rupture","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"10.3233\/HAB-210446_ref21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9343(03)00078-0","article-title":"Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation","volume":"114","author":"Meuwissen","year":"2003","journal-title":"Am J Med"},{"key":"10.3233\/HAB-210446_ref22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"10.3233\/HAB-210446_ref23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.3233\/HAB-210446_ref24","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","article-title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism","volume":"164","author":"Ziolkowska","year":"2000","journal-title":"J Immunol"},{"key":"10.3233\/HAB-210446_ref25","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","article-title":"Combination of IL-17 and TNF\u03b1 induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells","volume":"71","author":"Hot","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.3233\/HAB-210446_ref26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"issue":"10","key":"10.3233\/HAB-210446_ref27","first-page":"4390","article-title":"Associations among interleukin-17, interferon-gamma, and acute coronary syndrome","volume":"28","author":"Zhang","year":"2017","journal-title":"Biomedical Research"},{"key":"10.3233\/HAB-210446_ref28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2008.12.030","article-title":"Measurement of arterial stiffness in subjects with vascular disease: Are vessel wall changes more sensitive than increase in intima-media thickness","volume":"205","author":"Claridge","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.3233\/HAB-210446_ref29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2014.01.012","article-title":"Interleukin-17A in lipid metabolism and atherosclerosis","volume":"431C","author":"Yu","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.3233\/HAB-210446_ref30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/DMSO.S34220","article-title":"Predicting cardiometabolic risk: Waist-to-height ratio or BMI. A meta-analysis","volume":"6","author":"Savva","year":"2013","journal-title":"Diabetes Metab Syndr Obes"}],"container-title":["Human Antibodies"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/HAB-210446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:37Z","timestamp":1777447357000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/HAB-210446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":30,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/hab-210446","relation":{},"ISSN":["1875-869X","1093-2607"],"issn-type":[{"value":"1875-869X","type":"electronic"},{"value":"1093-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,18]]}}}